Prospective study of short‐term peginterferon‐α‐2a monotherapy in patients who had a virological response at 2 weeks after initiation of interferon therapy
Prospective study of short‐term peginterferon‐α‐2a monotherapy in patients who had a virological response at 2 weeks after initiation of interferon therapy
复制标题
对开始干扰素治疗后 2 周出现病毒学应答的患者进行短期聚乙二醇干扰素-α-2a 单药治疗的前瞻性研究
DOI：
--
复制
发表时间：
2008
影响因子：
4.1
通讯作者：
K. Chayama
中科院分区：
文献类型：
--
作者：
S. Jeong;Y. Kawakami;M. Kitamoto;Hiroto Ishihara;K. Tsuji;S. Aimitsu;H. Kawakami;K. Uka;S. Takaki;Hideaki Kodama;K. Waki;M. Imamura;H. Aikata;Shoichi Takahashi;K. Chayama
背景与目的： 长期干扰素治疗能有效消除丙型肝炎病毒。然而，它带来了不良影响和生活质量下降的风险。为了评估短期干扰素疗法是否有效地消除丙型肝炎病毒，我们进行了一项为期8周或24周的聚乙二醇化干扰素-α-2a治疗的前瞻性先导研究。
Background and Aims: Long‐term interferon (IFN) therapy is effective in eliminating hepatitis C virus (HCV). However, it carries the risk of adverse effects and reduced quality of life. To assess whether short‐term IFN therapy effectively eliminates HCV, we performed a prospective pilot study of pegylated (peg)IFN‐α‐2a therapy for 8 or 24 weeks.
影响因子：
29.4
作者：
McHutchison, JG;Manns, M;Albrecht, JK
通讯作者：
Albrecht, JK